StockData
Neurogene Inc. logo

Neurogene Inc. (NGNE) KPIs and segments

NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$23.10−0.20 (-0.86%)

Close on Nov 17, 2026Market cap $462.26MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Neurogene's business

Coming soon

This tab will track the numbers specific to Neurogene's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?